StockComparison Logo
vs

GSK vs SNY

Comparison between GSK Plc (GSK, Company) and Sanofi (SNY, Company).

Both GSK and SNY are from the Healthcare sector.

5-Year PerformanceGSK has outperformed SNY, delivering a return of +4.8% compared to +0.1%

GSK vs SNY - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
GSK
$104B
Winner
SNY
$105B
Max Drawdown
GSK
64.03%
Winner
SNY
49.96%
Sharpe Ratio
Winner
GSK
1.03
SNY
-0.26
5Y Beta
Winner
GSK
0.25
SNY
0.31
Industry
GSK
Drug Manufacturers - General
SNY
Drug Manufacturers - General
P/E Ratio
Winner
GSK
12.04
SNY
12.09
Forward P/E
GSK
11.38
Winner
SNY
8.87
PEG Ratio
Winner
GSK
0.10
SNY
0.39
Dividend Yield
GSK
3.40%
Winner
SNY
8.81%
5Y Dividends CAGR
GSK
1.34%
Winner
SNY
19.45%
5Y EPS CAGR
Winner
GSK
4.65%
SNY
-8.34%
Debt to Equity
GSK
106.74%
Winner
SNY
27.50%
Free Cash Flow Yield
GSK
8.07%
Winner
SNY
8.52%
P/S Ratio
GSK
3.13
Winner
SNY
2.26
P/B Ratio
GSK
4.31
Winner
SNY
1.28

GSK vs SNY - Historical Returns

Returns include dividend reinvestment.

1M
Winner
GSK
+5.15%
SNY
+2.60%
3M
GSK
-2.09%
Winner
SNY
+5.16%
6M
Winner
GSK
+7.79%
SNY
-3.29%
1Y
Winner
GSK
+33.69%
SNY
-6.40%
5Y(CAGR)
Winner
GSK
+4.81%
SNY
+0.14%
10Y(CAGR)
GSK
+5.21%
Winner
SNY
+5.64%
Max(CAGR)
GSK
+3.17%
Winner
SNY
+5.49%

GSK vs SNY - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearGSKSNY
2026+6.95%-4.11%
2025+50.62%+5.02%
2024-6.27%+0.50%
2023+9.25%+5.32%
2022-32.73%-0.66%
2021+23.62%+6.62%
2020-17.52%-0.53%
2019+30.36%+22.08%
2018+9.29%+5.16%
2017-3.80%+8.38%
2016+1.52%-0.09%
2015+0.48%-3.26%
2014-14.73%-8.70%
2013+26.97%+15.70%
2012-0.75%+33.41%
2011+22.51%+15.20%
2010-3.72%-17.19%
2009+20.27%+26.74%
2008-21.93%-26.44%
2007-2.77%+1.12%
2006+6.93%+2.95%
2005+9.96%+11.84%
2004+5.08%+8.64%
2003+25.04%+24.88%
2002-22.83%+2.12%
2001-9.58%N/A
2000+5.67%N/A
1999-5.78%N/A

GSK vs SNY Drawdown Comparison

The maximum drawdown for GSK was -50.11%, occurring on Sep 27, 2022. Recovery took 935 trading sessions.

The maximum drawdown for SNY was -46.47%, occurring on Mar 6, 2009. Recovery took 1512 trading sessions.

The current GSK drawdown is -13.24%. The current SNY drawdown is -18.72%.

RankGSKSNY
#1-50.11%
Apr 13, 2022 - Jan 6, 2026
-46.47%
Jul 26, 2006 - Jul 26, 2012
#2-49.64%
Apr 20, 2007 - Apr 18, 2012
-33.52%
May 24, 2022 - Apr 13, 2023
#3-45.23%
Apr 25, 2000 - Nov 11, 2005
-30.85%
Sep 22, 2014 - Oct 30, 2019
#4-32.56%
Jan 17, 2020 - Dec 10, 2021
-28.97%
Aug 9, 2002 - May 29, 2003
#5-27.97%
Mar 4, 2014 - Sep 3, 2019
-26.40%
Feb 6, 2020 - Jun 2, 2020
#6-26.98%
Nov 5, 1999 - Apr 11, 2000
-26.32%
Jan 22, 2004 - Nov 5, 2004
#7-18.61%
Feb 18, 2026 - Jun 2, 2026
-23.37%
Mar 6, 2025 - Mar 13, 2026
#8-14.45%
Jan 18, 2022 - Apr 7, 2022
-21.87%
Sep 20, 2023 - Jul 25, 2024
#9-10.52%
May 16, 2006 - Feb 13, 2007
-21.60%
Sep 4, 2024 - Mar 5, 2025
#10-10.48%
Oct 4, 2012 - Mar 22, 2013
-20.37%
Jun 18, 2003 - Nov 18, 2003
#11-8.45%
May 28, 2013 - Nov 1, 2013
-17.09%
Jul 8, 2002 - Aug 7, 2002
#12-8.43%
Apr 11, 2000 - Apr 25, 2000
-15.75%
Jul 20, 2020 - May 10, 2021
#13-8.16%
Nov 11, 2005 - Mar 8, 2006
-14.04%
May 28, 2013 - Jun 4, 2014
#14-7.54%
Feb 14, 2007 - Apr 16, 2007
-13.24%
Jun 14, 2021 - Apr 7, 2022
#15-7.37%
Jan 21, 2014 - Feb 13, 2014
-12.65%
May 26, 2005 - Dec 23, 2005

Correlation

Correlation between GSK and SNY is 0.87 which considered as a strong positive correlation - the stocks tend to move together.

0.87
-101

Dividend Comparison (2000 - 2026)

GSK vs SNY dividend yield comparison.

YearGSKSNY
20261.69%5.53%
20253.42%4.57%
20244.60%4.22%
20233.75%3.83%
20225.47%4.32%
20214.99%3.80%
20205.59%3.61%
20194.35%3.47%
20185.65%4.29%
20175.83%3.82%
20166.86%4.11%
20155.93%3.77%
20146.20%4.19%
20134.51%3.34%
20125.70%3.71%
20114.83%3.62%
20105.10%4.55%
20094.39%3.66%
20085.74%5.05%
20074.09%2.56%
20063.29%1.77%
20053.03%1.42%
20043.38%2.52%
20032.77%2.21%
20023.10%0.00%
20011.54%0.00%
20004.57%0.00%

Select Stocks to Compare